The Hydration Pharmaceuticals CoASX:HPC Buyback Yield % is -56.37 as of Jun. 30, 2026. The stock has 3 warning signs investors should review. Among 106 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 97.17% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co Buyback Yield % Chart
ASX:HPC vs SYY, USFD, PFGC: Buyback Yield % Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co Buyback Yield % vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co (ASX:HPC) has a Buyback Yield % of -56.37 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #103 out of 106 companies in the Retail - Defensive industry, placing it in the top 97.2%.
Is The Hydration Pharmaceuticals Co's Buyback Yield % too high?
The Hydration Pharmaceuticals Co's current Buyback Yield % is -56.37. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #103 out of 106 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's Buyback Yield % compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #103 out of 106 companies for Buyback Yield %. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median Buyback Yield % is 0.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Retail - Defensive company?
The median Buyback Yield % among Retail - Defensive companies is 0.25, based on 106 companies in the industry. Companies in the top quartile (top 25%) have a Buyback Yield % significantly above this median, while those in the bottom quartile fall well below. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median Buyback Yield % is 0.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current Buyback Yield % is -56.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Buyback Yield % of -56.37. The current Buyback Yield % is -56.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Buyback Yield % is -56.37 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 